Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The product performs just as well as Mounjaro
If you have any of these risk factors or symptoms, discuss them with your doctor before starting tirzepatide It is also important to note that tirzepatide has not been extensively studied in pregnant or breastfeeding women, so its safety in these populations is unknown, and therefore, it is best to be avoided
About this protocol Technical and clinical context our providers use when evaluating intake
You can head to our cost comparison tool for more detailed information on the cost of GLP-1 weight-loss medications
FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors Eli Lilly The FDA approved Eli Lilly and Companys Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
10 Witschi A, Reddy S, Stofer B, Lauterburg BH
